| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/14750708.5.6.797 |
| P50 | author | Patricia Bozza | Q38326687 |
| Pedro Póvoa | Q38330407 | ||
| Fernando A Bozza | Q56883542 | ||
| P2093 | author name string | Marcio Soares | |
| Jorge IF Salluh | |||
| P2860 | cites work | Hydrocortisone therapy for patients with septic shock | Q28264225 |
| Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia | Q57759353 | ||
| Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine | Q28280888 | ||
| Efficacy and safety of recombinant human activated protein C for severe sepsis | Q29547839 | ||
| Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study | Q33861751 | ||
| A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin | Q33891791 | ||
| Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems | Q33988265 | ||
| Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock | Q34145159 | ||
| Adrenal insufficiency in the critically ill: a new look at an old problem | Q34158471 | ||
| Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock | Q34314380 | ||
| Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death | Q34455153 | ||
| Reversal of late septic shock with supraphysiologic doses of hydrocortisone | Q34465500 | ||
| Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock | Q34466069 | ||
| The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study | Q34480786 | ||
| Adrenal function testing in patients with septic shock | Q35544715 | ||
| Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? | Q36165942 | ||
| Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force | Q36372988 | ||
| Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis | Q36392617 | ||
| Biomarkers of sepsis | Q36578012 | ||
| Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators | Q36927312 | ||
| Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. | Q37100944 | ||
| The role of corticosteroids in severe community-acquired pneumonia: a systematic review | Q37189110 | ||
| Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. | Q40481799 | ||
| Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) | Q41145565 | ||
| Cortisol response to corticotropin and survival in septic shock | Q43838319 | ||
| Adrenal function in patients with community-acquired pneumonia. | Q44126314 | ||
| Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study | Q45158566 | ||
| Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome | Q46865262 | ||
| C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study | Q47805298 | ||
| Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. | Q47880659 | ||
| Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis | Q48197421 | ||
| Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. | Q51898034 | ||
| Controversies of surviving sepsis campaign bundles: should we use them? | Q54058377 | ||
| Biomarkers of sepsis: Lost in translation?* | Q56798100 | ||
| SURVIVING SEPSIS CAMPAIGN | Q56798103 | ||
| P433 | issue | 6 | |
| P921 | main subject | sepsis | Q183134 |
| P304 | page(s) | 797-800 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Therapy: open access in clinical medicine | Q15753369 |
| P1476 | title | Current perspectives for the use of corticosteroids in sepsis: patient selection is the key | |
| P478 | volume | 5 |
Search more.